Vogl Thomas J, Wessling Johannes, Buerke Boris
Department of Diagnostic and Interventional Radiology, Johann Wolfgang Goethe University Frankfurt, Germany.
Acta Radiol. 2012 Oct 1;53(8):914-20. doi: 10.1258/ar.2012.120303. Epub 2012 Sep 14.
The use of pre-filled syringes for contrast media (CM) administration allows efficient and optimized workflow during radiologic diagnostic procedures, and reduces the risk of contamination, providing benefits for both patients and healthcare workers.
To compare the efficiency and safety of ioversol (Optiray(TM)) bottles and pre-filled syringes in clinical practice.
This was an observational, non-interventional, prospective, multicenter study conducted at 72 centers in Germany. Patients undergoing contrast-enhanced computed tomography (CT) examinations with ioversol were enrolled. The use of ioversol bottles and pre-filled syringes in the diagnostic procedure was recorded in terms of efficiency (residual volume, re-use of CM) and safety (adverse events [AEs]).
A total of 10,836 patients were enrolled and included in this study. Ioversol bottles and syringes were used in 72% and 28% of cases, respectively. Analysis of the volume of CM in bottles before and after examinations, together with the volume used during the examination, suggested that in 22.5% of cases a new bottle was connected during the procedure. Further analysis revealed that in 80.2% of cases, the remaining volume of CM in the bottles could potentially be used for subsequent investigations, compared with <1% of cases for pre-filled syringes. For the total study population, AEs and serious AEs were reported in 30 (0.28%) and four (0.037%) patients, respectively, with no significant difference observed between ioversol bottles and syringes.
Administration of ioversol for contrast-enhanced CT examinations is associated with a low incidence of AEs and is generally safe and well tolerated. Ioversol pre-filled syringes were associated with lower residual volumes and less potential re-use compared with bottles.
使用预填充注射器注射造影剂可在放射诊断过程中实现高效且优化的工作流程,并降低污染风险,对患者和医护人员均有益处。
比较碘海醇(欧乃派克)瓶装剂和预填充注射器在临床实践中的效率和安全性。
这是一项在德国72个中心进行的观察性、非干预性、前瞻性多中心研究。纳入接受碘海醇增强计算机断层扫描(CT)检查的患者。记录在诊断过程中使用碘海醇瓶装剂和预填充注射器的效率(残留量、造影剂再利用情况)和安全性(不良事件)。
本研究共纳入10836例患者。分别有72%和28%的病例使用了碘海醇瓶装剂和注射器。对检查前后瓶装造影剂的体积以及检查期间使用的体积进行分析表明,在22.5%的病例中,检查过程中连接了新的瓶装剂。进一步分析显示,在80.2%的病例中,瓶装造影剂的剩余量有可能用于后续检查,而预填充注射器的这一比例不到1%。对于整个研究人群,分别有30例(0.28%)和4例(0. ) 037%)患者报告了不良事件和严重不良事件,碘海醇瓶装剂和注射器之间未观察到显著差异。
碘海醇用于增强CT检查的不良事件发生率较低,总体安全且耐受性良好。与瓶装剂相比,碘海醇预填充注射器的残留量更低,再利用可能性更小。